Knight Therapeutics Inc. (TSX:GUD)
9.66
+0.03 (0.31%)
Aug 21, 2026, 4:00 PM EST
Knight Therapeutics Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 547.31 | 450.09 | 371.3 | 328.2 | 293.56 | 243.48 |
Revenue Growth | 42.32% | 21.22% | 13.13% | 11.80% | 20.57% | 22.03% |
Gross Profit Gross Profit Growth | 259.26 | 200.23 | 174.41 | 152.65 | 138.06 | 115.41 |
Operating Income Operating Income Growth | 21.93 | -2.35 | 7.4 | 6.37 | -17.06 | -12.83 |
Net Income Net Income Growth | 14.87 | -5.37 | 4.33 | -16.84 | -29.89 | 15.68 |
Earnings Per Share EPS Growth | 0.15 | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 |
EPS Growth | 8835.08% | - | - | - | - | -60.55% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Brazil Brazil Growth | 207.96 | 182.52 | 180.63 | 168.22 | 134.73 | 97.2 |
Canada Canada Growth | 142.93 | 84.28 | 25.69 | 19.67 | 11.35 | 7.7 |
Colombia Colombia Growth | 61.85 | 55 | 51.48 | 44.63 | 48.15 | 43.52 |
Argentina Argentina Growth | 46.52 | 40.75 | 45.9 | 24.1 | 46.13 | 42.96 |
Mexico Mexico Growth | 27.37 | 24.5 | 18.99 | 15.89 | - | - |
Rest of The Latin America Rest of The Latin America Growth | 37.88 | 43.02 | 38.83 | 39.22 | 40.17 | 40.95 |
Other Other Growth | 22.81 | 20.02 | 9.78 | 16.48 | 13.05 | 11.15 |
Total Total Growth | 547.31 | 450.09 | 371.3 | 328.2 | 293.56 | 243.48 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 121.17 | 114.23 | 172.84 | 177.28 | 200.78 | 160.16 |
Total Debt Total Debt Growth | 34.28 | 77.91 | 49.46 | 69.09 | 77.7 | 40.96 |
Net Cash (Debt) Net Cash Growth | 86.9 | 36.32 | 123.38 | 108.18 | 123.08 | 119.2 |
Net Cash Growth | 644.10% | -70.56% | 14.04% | -12.10% | 3.26% | -67.36% |
Net Cash Per Share Net Cash Per Share Growth | 0.87 | 0.36 | 1.22 | 1.01 | 1.07 | 0.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 115.25 | 68.96 | 36.28 | 35.94 | 45 | 44.62 |
Capital Expenditures CapEx Growth | -4.89 | -1.91 | -2.47 | -0.95 | -2.89 | -3.83 |
Free Cash Flow Free Cash Flow Growth | 110.36 | 67.05 | 33.81 | 34.99 | 42.12 | 40.79 |
Free Cash Flow Growth | 286.27% | 98.30% | -3.37% | -16.92% | 3.26% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.37% | 44.49% | 46.97% | 46.51% | 47.03% | 47.40% |
Operating Margin | 4.01% | -0.52% | 1.99% | 1.94% | -5.81% | -5.27% |
Pretax Margin | 3.91% | -1.49% | 0.55% | -6.70% | -14.97% | 2.75% |
Profit Margin | 2.72% | -1.19% | 1.17% | -5.13% | -10.18% | 6.44% |
FCF Margin | 20.16% | 14.90% | 9.11% | 10.66% | 14.35% | 16.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 64.19 | - | 123.63 | - | - | 40.16 |
Forward PE | 78.61 | 201.67 | 157.06 | 79.24 | 95.37 | 82.43 |
P/FCF Ratio | 8.57 | 8.96 | 15.84 | 15.45 | 13.86 | 15.44 |
PS Ratio | 1.73 | 1.34 | 1.44 | 1.65 | 1.99 | 2.59 |